Vyne Therapeutics Inc share price logo

Vyne Therapeutics Inc Share Price

NASDAQ: VYNE

Small Cap

$0.61

-0.01

(-1.20%)

as on

Vyne Therapeutics Inc Stock Performance

as on April 18, 2026 at 6:56 am IST

  • Day's High

    $0.61
    $0.63

    3.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.28
    $1.99
    downward going graph

    54.02%

    Downside

    226.77%

    Upside

    downward going graph

Vyne Therapeutics Inc share price movements today

Previous Close
$0.62
Open
$0.62
Volume
1.2M
Day's Low - High
$0.61 - $0.63
52 Week Low - High
$0.28 - $1.99

Vyne Therapeutics Inc Historical Returns

1 Month Return
+ 4.34 %
3 Month Return
+ 7.64 %
1 Year Return
-67.02 %
3 Year Return
-80.51 %
5 Year Return
-99.37 %

Vyne Therapeutics Inc Stock Fundamentals & Key Indicators

Check Vyne Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.6M

EPS (TTM)

-1.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-29.7M

Revenue (TTM)

570.0K

Profit Margin

0.00%

Return On Equity TTM

-66.96%

Vyne Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vyne Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Vyne Therapeutics Inc image
Vyne Therapeutics Inc
BUY$20.6M-99.37%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.3B122.97%133.478.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B101.1%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$37.2BNA131.655.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B49.34%17.9831.41%

Stock Returns calculator for Vyne Therapeutics Inc Stock including INR - Dollar returns

The Vyne Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vyne Therapeutics Inc investment value today

Current value as on today

₹35,836

Returns

-₹64,164

(-64.16%)

Returns from Vyne Therapeutics Inc Stock

-₹67,027 (-67.03%)

Dollar Impact

₹2,863 (+2.86%)

Analyst Recommendation on Vyne Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Vyne Therapeutics Inc. Average target price of $2

Vyne Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Vyne Therapeutics Inc.

What analysts predicted

69.5%UPSIDE

Target Price

$2

Current Price

$0.61

Analyzed by

9 Analysts

Target

$2.00

Vyne Therapeutics Inc target price $2, a slight upside of 69.5% compared to current price of $0.61. According to 9 analysts rating.

Vyne Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Vyne Therapeutics Inc Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Vyne Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-6
-6
-7
-10
-13
-12
-9
-7
-7
-5
EBITDA
-6
-6
-7
-9
-13
-12
-9
-7
-7
-5
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
0
0
0
0
Income Before Tax
-6
-6
-6
-9
-12
-12
-8
-5
-7
-4
Income Tax Expense
0
0
0
0
-
0
0
-
0
0
Net Income
-6
-6
-6
-9
-12
-12
-8
-5
-7
-4
Net Profit Margin
-5775.44%
-8142.11%
-6376.53%
-4750.51%
-10047.11%
-14311.90%
-4262.87%
-8340.58%
-4307.69%
-3720.77%

Vyne Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
4
10
1
20
0
0
0
0
0
Gross Profit
0
4
10
0
19
0
0
0
0
0
Operating Income
-14
-29
-54
-76
252
-38
-34
-29
-43
-29
EBITDA
-14
-29
-54
-75
-251
-38
-34
-29
-43
-26
Interest Expense
-
0
3
2
4
5
10
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-29
-51
-73
-255
-43
-33
-27
-39
-26
Income Tax Expense
0
0
3
-3
0
0
0
0
0
0
Net Income
-14
-29
-51
-70
-255
-73
-23
-28
-39
-26
Net Profit Margin
-2087.24%
-634.57%
-483.51%
-4026.51%
-1217.40%
-7876.37%
-4865.83%
-6710.38%
-7950.90%
-4646.14%

Vyne Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-6
-9
-12
-12
-8
-5
-7
-4
Operating Cash Flow
-5
-7
-8
-8
-8
-11
-10
-7
-3
Investing Cash Flow
-62
-3
19
-4
12
19
4
4
8
Financing Cash Flow
82
0
0
0
0
0
0
0
0
Change in Cash
15
-11
10
-13
3
8
-6
-2
4

Vyne Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-51
-73
-255
-73
-23
-28
-39
-26
Operating Cash Flow
-28
-52
-65
-137
-56
-29
-25
-33
-33
Investing Cash Flow
-15
-33
41
89
1
15
-57
23
37
Financing Cash Flow
49
125
4
61
39
1
82
0
0
Change in Cash
6
39
-18
13
-15
-11
0
-10
4

Global Institutional Holdings in Vyne Therapeutics Inc

Funds
Holdings
KVP Capital Advisors, LP
1.5%
State Street Corp
0.05%
Ikarian Capital, LLC
0.8%
Schonfeld Strategic Advisors LLC
0.64%
ADAR1 Capital Management LLC
0.76%
See all

Insights on Vyne Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, VYNE stock has moved up by 62.3%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.28M → -4.83M (in $), with an average increase of 50.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 111.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 40.2% return, outperforming this stock by 107.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 169.0K → 130.0K (in $), with an average decrease of 23.1% per quarter

About Vyne Therapeutics Inc

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor in Phase 1b trial for the acute control and chronic management of immune-mediated inflammatory conditions. VYNE Therapeutics Inc. was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. The company was founded in 2003 and is based in Stewartsville, New Jersey.
OrganisationVyne Therapeutics Inc
HeadquartersP.O. BOX 125, Stewartsville, NJ, United States, 08886
IndustryBiotechnology
CEOMr. David T. Domzalski
E-voting on sharesClick here to vote

Key Management of Vyne Therapeutics Inc

Name

Title

Mr. Tyler Zeronda CPA

CFO & Treasurer

Dr. Darrell S. Rigel FAAD, M.D.

Consultant

Mr. David T. Domzalski

CEO, President & Director

Dr. Iain A. Stuart Ph.D.

Chief Scientific Officer

Ms. Mutya Harsch J.D.

General Counsel, Chief Legal Officer & Company Secretary

FAQs

What is Vyne Therapeutics Inc share price today?

Vyne Therapeutics Inc share price today is $0.61 as on at the close of the market. Vyne Therapeutics Inc share today touched a day high of $0.63 and a low of $0.61.

What is the 52 week high and 52 week low for Vyne Therapeutics Inc share?

Vyne Therapeutics Inc share touched a 52 week high of $1.99 on and a 52 week low of $0.28 on . Vyne Therapeutics Inc stock price today i.e. is closed at $0.61,which is 69.40% down from its 52 week high and 117.47% up from its 52 week low.

What is Vyne Therapeutics Inc's market capitalisation today?

Vyne Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Vyne Therapeutics Inc Stock (VYNE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vyne Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vyne Therapeutics Inc Shares that will get you 2.4590 shares as per Vyne Therapeutics Inc share price of $0.61 per share as on April 18, 2026 at 1:26 am IST.

What is the minimum amount required to buy Vyne Therapeutics Inc Stock (VYNE) from India?

Indian investors can start investing in Vyne Therapeutics Inc (VYNE) shares with as little as ₹92.575 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹925.75 in Vyne Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vyne Therapeutics Inc share’s latest price of $0.61 as on April 18, 2026 at 1:26 am IST, you will get 16.3934 shares of Vyne Therapeutics Inc. Learn more about fractional shares .

What are the returns that Vyne Therapeutics Inc has given to Indian investors in the last 5 years?

Vyne Therapeutics Inc stock has given -99.37% share price returns and 24.3% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?